Premium
Healthcare Services Group Inc (HCSG)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Mr. Vikas SinghExec. VP & CFO | -935,00 | 0,00 | Derivative Exercise and Sale | - | 3,35k | - |
| 2026-05-27 | Mr. Vikas SinghExec. VP & CFO | 1,27k | 0,00 | Derivative Exercise and Retained Stock | - | 3,35k | 60,91% |
| 2026-02-26 | Mr. Andrew M. BrophySenior VP, Controller & CAO | -2,49k | 54,16k | Vente | 21,75 | 0,00 | -100,00% |
| 2026-02-24 | Mr. Andrew M. BrophySenior VP, Controller & CAO | -239,00 | 5,11k | Sale to Issuer | 21,40 | 0,00 | -100,00% |
| 2026-02-24 | Mr. Andrew W. KushExec. VP & COO | 9,81k | 0,00 | Derivative Exercise and Retained Stock | - | 38,34k | 34,37% |
| 2026-02-24 | Mr. Andrew W. KushExec. VP & COO | -7,23k | 154,66k | Derivative Exercise and Sale | 21,40 | 38,34k | - |
| 2026-02-24 | Mr. Patrick J. OrrExec. VP & Chief Revenue Officer | 7,42k | 0,00 | Derivative Exercise and Retained Stock | - | 7,42k | - |
| 2026-02-24 | Mr. Patrick J. OrrExec. VP & Chief Revenue Officer | -5,47k | 116,97k | Derivative Exercise and Sale | 21,40 | 7,42k | - |
| 2026-02-24 | Mr. Theodore WahlPresident, CEO & Director | 49,40k | 0,00 | Derivative Exercise and Retained Stock | - | 536,26k | 10,15% |
| 2026-02-24 | Mr. Theodore WahlPresident, CEO & Director | -36,39k | 778,81k | Derivative Exercise and Sale | 21,40 | 536,26k | - |
| 2026-02-24 | Mr. John Christopher SheaExec. VP & Chief Administrative Officer | 9,81k | 0,00 | Derivative Exercise and Retained Stock | - | 39,10k | 33,48% |
| 2026-02-24 | Mr. John Christopher SheaExec. VP & Chief Administrative Officer | -7,23k | 154,66k | Derivative Exercise and Sale | 21,40 | 39,10k | - |
| 2026-02-24 | Mr. Jason J. BundickExec. VP, CCO, General Counsel & Secretary | 7,49k | 0,00 | Derivative Exercise and Retained Stock | - | 35,36k | 26,89% |
| 2026-02-24 | Mr. Jason J. BundickExec. VP, CCO, General Counsel & Secretary | -5,52k | 118,19k | Derivative Exercise and Sale | 21,40 | 35,36k | - |
| 2026-02-18 | Mr. Patrick J. OrrExec. VP & Chief Revenue Officer | -44,62k | 915,83k | Vente | 20,52 - 20,55 | 0,00 | -100,00% |
| 2026-02-18 | Mr. Patrick J. OrrExec. VP & Chief Revenue Officer | -45,50k | 269,23k | Derivative Exercise and Sale | 10,36 - 20,54 | 44,62k | - |
| 2026-02-18 | Mr. John Christopher SheaExec. VP & Chief Administrative Officer | -38,86k | 128,45k | Derivative Exercise and Sale | 13,72 - 20,36 | 29,29k | - |
| 2026-02-18 | Mr. John Christopher SheaExec. VP & Chief Administrative Officer | -15,50k | 318,06k | Vente | 20,52 | 29,29k | -34,60% |
| 2026-02-17 | Mr. Theodore WahlPresident, CEO & Director | -8,51k | 178,14k | Sale to Issuer | 20,93 | 486,86k | -1,72% |
| 2026-01-03 | Mr. John Christopher SheaExec. VP & Chief Administrative Officer | 9,67k | 0,00 | Derivative Exercise and Retained Stock | - | 44,79k | 27,54% |
| 2026-01-03 | Mr. John Christopher SheaExec. VP & Chief Administrative Officer | -7,68k | 0,00 | Derivative Exercise and Sale | - | 44,79k | - |
| 2026-01-03 | Mr. Patrick J. OrrExec. VP & Chief Revenue Officer | 8,38k | 0,00 | Derivative Exercise and Retained Stock | - | 44,62k | 23,13% |
| 2026-01-03 | Mr. Patrick J. OrrExec. VP & Chief Revenue Officer | -6,82k | 0,00 | Derivative Exercise and Sale | - | 44,62k | - |
| 2026-01-03 | Mr. Theodore WahlPresident, CEO & Director | 49,35k | 0,00 | Derivative Exercise and Retained Stock | - | 486,86k | 11,28% |
| 2026-01-03 | Mr. Theodore WahlPresident, CEO & Director | -35,45k | 0,00 | Derivative Exercise and Sale | - | 486,86k | - |
| 2026-01-03 | Mr. Jason J. BundickExec. VP, CCO, General Counsel & Secretary | 7,36k | 0,00 | Derivative Exercise and Retained Stock | - | 27,87k | 35,89% |
| 2026-01-03 | Mr. Jason J. BundickExec. VP, CCO, General Counsel & Secretary | -6,09k | 0,00 | Derivative Exercise and Sale | - | 27,87k | - |
| 2026-01-03 | Mr. Andrew W. KushExec. VP & COO | 9,67k | 0,00 | Derivative Exercise and Retained Stock | - | 28,53k | 51,29% |
| 2026-01-03 | Mr. Andrew W. KushExec. VP & COO | -7,68k | 0,00 | Derivative Exercise and Sale | - | 28,53k | - |
| 2026-01-03 | Mr. Vikas SinghExec. VP & CFO | -1,90k | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2026-01-03 | Mr. Vikas SinghExec. VP & CFO | 2,08k | 0,00 | Derivative Exercise and Retained Stock | - | - | - |
| 2026-01-04 | Mr. Andrew M. BrophySenior VP, Controller & CAO | -695,00 | 0,00 | Derivative Exercise and Sale | - | 2,00k | - |
| 2026-01-04 | Mr. Andrew M. BrophySenior VP, Controller & CAO | -241,00 | 0,00 | Sale to Issuer | - | 2,00k | -10,75% |
| 2025-10-27 | Mr. Jason J. BundickExec. VP, CCO, General Counsel & Secretary | -21,00k | 399,76k | Sale to Issuer | 19,04 | 20,51k | -50,59% |
| 2025-10-28 | Mr. Andrew W. KushExec. VP & COO | -28,61k | 547,35k | Sale to Issuer | 19,13 | 18,86k | -60,27% |
| 2025-07-28 | Mr. John Christopher SheaExec. VP & Chief Administrative Officer | -21,37k | 283,13k | Vente | 13,25 | 32,98k | -39,32% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
